Concepedia

Farhad Peerani

FP

10

Publications

882

Citations

10

H-Index

2016

Active since

Affiliations

University of Alberta(Current)

University of Calgary

University of California San Diego

Lenox Hill Hospital

McMaster University

Farhad Peerani is an author at University of Alberta specializing in rheumatoid arthritis, immunology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2016–2024

10

Publications

10

The Real-World Effectiveness and Safety of Vedolizumab for Moderate–Severe Crohn’s Disease: Results From the US VICTORY Consortium

Parambir S. Dulai, Siddharth Singh, Xiaoqian Jiang et al. · The American Journal of Gastroenterology · 2016 · 314 citations

Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium

Neeraj Narula, Farhad Peerani, Joseph Meserve et al. · The American Journal of Gastroenterology · 2018 · 171 citations

Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn’s Disease

Parambir S. Dulai, Brigid S. Boland, Siddharth Singh et al. · Gastroenterology · 2018 · 140 citations · Full text

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 89 citations · Full text

, , +7

The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium

Amanda M. Johnson, Maria Barsky, Waseem Ahmed et al. · The American Journal of Gastroenterology · 2022 · 63 citations

Rows per page

1–5 of 10